Status:
WITHDRAWN
Gabapentin in the Post-cesarean Pain Management of Buprenorphine Patient
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Cesarean Delivery
Pain Management
Eligibility:
FEMALE
18-50 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether a perioperative course of gabapentin in parturients on buprenorphine maintenance would improve analgesia after elective cesarean delivery (CD).
Detailed Description
Many strategies have been suggested to improve post-CD pain management in parturients on buprenorphine. While effective pain relief can be achieved, women maintained on buprenorphine during pregnancy ...
Eligibility Criteria
Inclusion
- singleton, term pregnancy
- currently on buprenorphine maintenance therapy
- scheduled for elective CD under spinal anesthesia
Exclusion
- use illicit drugs or relapse during the last trimester of pregnancy
- positive drug screen at the time of delivery
- allergies to any medications used in the study
- taking prescribed gabapentin at the time of admission for CD
- contraindications to neuraxial anesthesia or require general anesthesia for CD
- designated ASA physical status 4 or above
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03335436
Start Date
April 1 2018
End Date
December 1 2020
Last Update
February 18 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.